Stocks and Investing Stocks and Investing
Fri, November 6, 2020
Thu, November 5, 2020

Matthew O"Brien Maintained (ZBH) at Buy and Held Target at $160 on, Nov 5th, 2020


Published on 2024-10-27 14:39:11 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy and Held Target at $160 on, Nov 5th, 2020.

Matthew has made no other calls on ZBH in the last 4 months.

There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 1 agrees with Matthew"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

Jason Wittes of "Northland Capital Markets" Initiated at Hold and Held Target at $150 on, Tuesday, October 20th, 2020

These are the ratings of the 5 analyists that currently disagree with Matthew;

Lawrence Keusch of "Raymond James" Maintained at Strong Buy with Increased Target to $170 on, Monday, October 12th, 2020
Richard Newitter of "SVB Leerink" Maintained at Buy with Increased Target to $160 on, Monday, October 5th, 2020
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, August 5th, 2020
Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $162 on, Wednesday, August 5th, 2020
Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $155 on, Wednesday, August 5th, 2020

Contributing Sources